04 December 2019 |

Anaconda Biomed secures €20 Million round of funding

BARCELONA, Spain – Anaconda Biomed S,L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has closed €20 million in new funding. The funding will be used for clinical studies of the company’s groundbreaking technology, regulatory submissions in international markets, further product development and manufacturing scale-up. “With this new round of funding, we will be

31 March 2020 |

Beintoo sold to Publitalia ’80 (Mediaset Group)

Innogest Capital is pleased to share the announcement of the sale of Beintoo to Publitalia '80, part of Mediaset Group. Beintoo is an exciting company and this transaction demonstrate our commitment to invest in and build innovative companies. This is particularly relevant news, given the current difficult environment. Below the press release issued on tuesday by Mediaset Group (in italian).

Tags: , , ,
04 December 2019 |

Hiroaki Tanaka and Hadi Abderrahim appointed Partners at Innogest Capital

MILAN (ITALY), DECEMBER 4th 2019 – Hiroaki Tanaka and Hadi Abderrahim have been appointed  partners by Innogest SGR’s Board of directors. They will join Claudio Giuliano and Giovanni Leo as senior team within Innogest’s healthcare practice, and strengthen specifically the oncology and precision medicine team, one of the signature verticals of the investment firm. Hiroaki Tanaka is an expert in

Tags: ,
25 September 2019 |

Newronika raises €8.4M Series A Round

MILAN, 25th SEPTEMBER 2019 – Newronika, a spin-off of world-class neurological research center Policlinico of Milan and University of Milan, has raised an 8.4 million Euros Series-A round. The investment was led by French venture capital fund Omnes together withexisting investors Innogest and Indaco Venture Partners SGR (“Indaco SGR”) on behalf of Indaco Ventures I and Atlante Ventures funds.

Tags: , ,